Treatment of Genitourinary Syndrome of Menopause After Breast Cancer With PRP
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine the safety, feasibility and preliminary efficacy of
use of platelet rich plasma (PRP) treatment in female breast cancer survivors with
genitourinary syndrome of menopause (GSM)